Telix Participates in UBS Global Biopharma Conference

PUBT · 2d ago
Telix Participates in UBS Global Biopharma Conference
  • Telix Pharmaceuticals will participate in the UBS Global Biopharma Conference in London on Nov. 17, 2026.
  • Group CEO Christian Behrenbruch and Therapeutics CEO Richard Valeix will join a fireside chat at 9:20 a.m. GMT, webcast live.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.